BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16164929)

  • 1. Staged sentinel lymph node biopsy before mastectomy facilitates surgical planning for breast cancer patients.
    Klauber-Demore N; Calvo BF; Hultman CS; Kim HJ; Meyers MO; Damitz L; Frank JS; Stitzenberg KB; Sartor CI; Ollila DW
    Am J Surg; 2005 Oct; 190(4):595-7. PubMed ID: 16164929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sentinel lymph node biopsy followed by delayed mastectomy and reconstruction.
    Brady B; Fant J; Jones R; Grant M; Andrews V; Livingston S; Kuhn J
    Am J Surg; 2003 Feb; 185(2):114-7. PubMed ID: 12559439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of internal mammary lymph node biopsy on the therapeutic decision and survival of patients with breast cancer.
    Ozmen V; Ozcinar B; Bozdogan A; Eralp Y; Yavuz E; Dincer M
    Eur J Surg Oncol; 2015 Oct; 41(10):1368-72. PubMed ID: 26210653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic mastectomy in patients at high risk: is there a role for sentinel lymph node biopsy?
    Murthy V; Chamberlain RS
    Clin Breast Cancer; 2013 Jun; 13(3):180-7. PubMed ID: 23357305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel lymph node biopsy before mastectomy and immediate breast reconstruction does not significantly delay surgery in early breast cancer.
    Mannu GS; Navi A; Hussien M
    ANZ J Surg; 2015 Jun; 85(6):438-43. PubMed ID: 24754896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel lymph node biopsy in contralateral prophylactic mastectomy: are we overtreating? Experience at a tertiary care hospital.
    Kuwajerwala NK; Dekhne NS; Pentiak PA; Fend D; Callahan RE; Amine M; Lucia V; Swartz J
    Clin Breast Cancer; 2013 Aug; 13(4):287-91. PubMed ID: 23706482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel lymph node biopsy in breast cancer New indications and our experience.
    Zanghì G; Rinzirillo NM; Caponnetto AM; Vecchio R; Catania V; Leanza V
    Ann Ital Chir; 2015; 86():508-12. PubMed ID: 26898363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of Positive Sentinel Lymph Node After Neoadjuvant Systemic Therapy in Clinically Node-Negative Breast Cancer: Implications for Postmastectomy Radiation Therapy and Immediate Breast Reconstruction.
    Samiei S; van Kaathoven BN; Boersma L; Granzier RWY; Siesling S; Engelen SME; de Munck L; van Kuijk SMJ; van der Hulst RRJW; Lobbes MBI; Smidt ML; van Nijnatten TJA
    Ann Surg Oncol; 2019 Nov; 26(12):3902-3909. PubMed ID: 31359276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is Sentinel Lymph Node Biopsy Necessary for Ductal Carcinoma In Situ Patients Undergoing Mastectomy?
    Miller-Ocuin JL; Howard-McNatt M; Levine EA; Chiba A
    Am Surg; 2020 Aug; 86(8):955-957. PubMed ID: 32862671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer.
    Choi SH; Barsky SH; Chang HR
    Breast J; 2003; 9(3):153-62. PubMed ID: 12752622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of sentinel lymph node biopsy in women undergoing prophylactic mastectomy.
    Dupont EL; Kuhn MA; McCann C; Salud C; Spanton JL; Cox CE
    Am J Surg; 2000 Oct; 180(4):274-7. PubMed ID: 11113434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-mastectomy sentinel lymph node biopsy: a strategy to enhance outcomes in immediate breast reconstruction.
    Teven C; Agarwal S; Jaskowiak N; Park JE; Chhablani A; Seitz IA; Song DH
    Breast J; 2013; 19(5):496-503. PubMed ID: 23773780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
    Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
    Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
    Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
    J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial axillary lymph node dissection inferior to the intercostobrachial nerves complements sentinel node biopsy in patients with clinically node-negative breast cancer.
    Li J; Jia S; Zhang W; Qiu F; Zhang Y; Gu X; Xue J
    BMC Surg; 2015 Jun; 15():79. PubMed ID: 26123412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of sentinel lymph node detection by methylene blue and carbon nanoparticle suspension injection in early breast cancer].
    Ge J; Yan B; Cao XC
    Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):226-8. PubMed ID: 21575525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraoperative detection of sentinel lymph node metastases in breast carcinoma by Fourier transform infrared spectroscopy.
    Tian P; Zhang W; Zhao H; Lei Y; Cui L; Zhang Y; Xu Z
    Br J Surg; 2015 Oct; 102(11):1372-9. PubMed ID: 26198697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy.
    Langer I; Marti WR; Guller U; Moch H; Harder F; Oertli D; Zuber M
    Ann Surg; 2005 Jan; 241(1):152-8. PubMed ID: 15622003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of sentinel lymph node biopsy in breast cancer surgery with simple pathology facilities--an Iranian local experience with a review of potential causes of false negative results.
    Amoui M; Akbari ME; Tajeddini A; Nafisi N; Raziei G; Modares SM; Hashemi M
    Asian Pac J Cancer Prev; 2012; 13(11):5385-9. PubMed ID: 23317188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Axillary Management of Stage II/III Breast Cancer in Patients Treated with Neoadjuvant Systemic Therapy: Results of CALGB 40601 (HER2-Positive) and CALGB 40603 (Triple-Negative).
    Ollila DW; Cirrincione CT; Berry DA; Carey LA; Sikov WM; Hudis CA; Winer EP; Golshan M
    J Am Coll Surg; 2017 Apr; 224(4):688-694. PubMed ID: 28089784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.